Ramsay Générale de Santé SA (EPA:GDS)
10.60
-0.05 (-0.47%)
At close: Mar 13, 2026
Ramsay Générale de Santé Revenue
Ramsay Générale de Santé had revenue of 2.59B EUR in the half year ending December 31, 2025, with 9.24% growth. This brings the company's revenue in the last twelve months to 5.32B, up 4.90% year-over-year. In the fiscal year ending June 30, 2025, Ramsay Générale de Santé had annual revenue of 5.24B with 4.70% growth.
Revenue (ttm)
5.32B
Revenue Growth
+4.90%
P/S Ratio
0.22
Revenue / Employee
133.10K
Employees
40,000
Market Cap
1.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 5.24B | 235.50M | 4.70% |
| Jun 30, 2024 | 5.01B | 305.00M | 6.49% |
| Jun 30, 2023 | 4.70B | 400.50M | 9.31% |
| Jun 30, 2022 | 4.30B | 278.40M | 6.92% |
| Jun 30, 2021 | 4.02B | 276.40M | 7.38% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 46.72B |
| EssilorLuxottica Société anonyme | 28.49B |
| Clariane SE | 5.31B |
| Ipsen | 3.93B |
| Sartorius Stedim Biotech | 2.97B |
| Vetoquinol | 532.39M |
| Valneva SE | 179.91M |
| MedinCell | 32.44M |